COVID-19 Incidence in Patients With Immunomediated Inflammatory Diseases: Influence of Immunosuppressant Treatments

The effect of immunosuppressant treatments on the incidence of coronavirus disease (COVID-19) remains largely unknown. We studied the association between the pre-exposure to disease-modifying antirheumatic drugs (DMARDs) that decrease immunological responses and the incidence of COVID-19 to explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Soldevila-Domenech, Natalia, Tío, Laura, Llorente-Onaindia, Jone, Martín-García, Elena, Nebot, Pau, de la Torre, Rafael, Gurt, Alba, Maldonado, Rafael, Monfort, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845571/
https://www.ncbi.nlm.nih.gov/pubmed/33519443
http://dx.doi.org/10.3389/fphar.2020.583260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845571/
https://www.ncbi.nlm.nih.gov/pubmed/33519443
http://dx.doi.org/10.3389/fphar.2020.583260

Ejemplares similares